Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.

2014-05-01/in Seaman

Bournazos S, Klein F, Pietzsch J, Seaman MS, Nussenzweig MC, Ravetch JV. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell. 2014, 158(6):1243-53. [Article]

Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates